176 related articles for article (PubMed ID: 27992551)
1. Affluence and Private Health Insurance Influence Treatment and Survival in Non-Hodgkin's Lymphoma.
Comber H; De Camargo Cancela M; Haase T; Johnson H; Sharp L; Pratschke J
PLoS One; 2016; 11(12):e0168684. PubMed ID: 27992551
[TBL] [Abstract][Full Text] [Related]
2. Causes and outcomes of emergency presentation of rectal cancer.
Comber H; Sharp L; de Camargo Cancela M; Haase T; Johnson H; Pratschke J
Int J Cancer; 2016 Sep; 139(5):1031-9. PubMed ID: 27087482
[TBL] [Abstract][Full Text] [Related]
3. Total registration of non-Hodgkin's lymphoma and Hodgkin's disease in Scotland: effect of deprivation and caseload on outcome.
Ewing JC; White JM; Rattray A; Lessells A; Mackie MJ
Hematology; 2003 Aug; 8(4):211-20. PubMed ID: 12911938
[TBL] [Abstract][Full Text] [Related]
4. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis.
Rueffer U; Josting A; Franklin J; May M; Sieber M; Breuer K; Engert A; Diehl V;
J Clin Oncol; 2001 Apr; 19(7):2026-32. PubMed ID: 11310450
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of co-morbidity and its relationship to treatment among unselected patients with Hodgkin's disease and non-Hodgkin's lymphoma, 1993-1996.
van Spronsen DJ; Janssen-Heijnen ML; Breed WP; Coebergh JW
Ann Hematol; 1999 Jul; 78(7):315-9. PubMed ID: 10466443
[TBL] [Abstract][Full Text] [Related]
6. Age-related prognostic factor analysis in non-Hodgkin's lymphoma.
Maksymiuk AW; Haines C; Tan LK; Skinnider LF
Can J Oncol; 1996 Jun; 6(1):435-42. PubMed ID: 8853516
[TBL] [Abstract][Full Text] [Related]
7. Primary extranodal non-Hodgkin's lymphoma in adults: clinicopathological and survival characteristics.
Economopoulos T; Asprou N; Stathakis N; Papageorgiou E; Dervenoulas J; Xanthaki K; Raptis S
Leuk Lymphoma; 1996 Mar; 21(1-2):131-6. PubMed ID: 8907280
[TBL] [Abstract][Full Text] [Related]
8. Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma.
Horning SJ; Negrin RS; Chao JC; Long GD; Hoppe RT; Blume KG
J Clin Oncol; 1994 Dec; 12(12):2552-8. PubMed ID: 7989928
[TBL] [Abstract][Full Text] [Related]
9. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.
Peniket AJ; Ruiz de Elvira MC; Taghipour G; Cordonnier C; Gluckman E; de Witte T; Santini G; Blaise D; Greinix H; Ferrant A; Cornelissen J; Schmitz N; Goldstone AH;
Bone Marrow Transplant; 2003 Apr; 31(8):667-78. PubMed ID: 12692607
[TBL] [Abstract][Full Text] [Related]
10. Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: a new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data. Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Majolino I; Pearce R; Taghipour G; Goldstone AH
J Clin Oncol; 1997 Feb; 15(2):509-17. PubMed ID: 9053472
[TBL] [Abstract][Full Text] [Related]
11. Hodgkin's and non-Hodgkin's lymphoma of the head and neck.
Urquhart A; Berg R
Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular mortality trends in non-Hodgkin's lymphoma: a population-based cohort study.
Kamel MG; El-Qushayri AE; Thach TQ; Huy NT
Expert Rev Anticancer Ther; 2018 Jan; 18(1):91-100. PubMed ID: 29192533
[TBL] [Abstract][Full Text] [Related]
13. Tumor bulk as a prognostic factor for the management of localized aggressive non-Hodgkin's lymphoma: a survey of the Japan Lymphoma Radiation Therapy Group.
Oguchi M; Ikeda H; Isobe K; Hirota S; Hasegawa M; Nakamura K; Sasai K; Hayabuchi N
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):161-8. PubMed ID: 10924986
[TBL] [Abstract][Full Text] [Related]
14. The National Cancer Data Base report on non-Hodgkin's lymphoma.
Glass AG; Karnell LH; Menck HR
Cancer; 1997 Dec; 80(12):2311-20. PubMed ID: 9404709
[TBL] [Abstract][Full Text] [Related]
15. Non-Hodgkin's lymphoma in Saskatchewan. A review of 10 years' experience.
Maksymiuk AW; Bratvold JS; Ezzat W; Tan LK; Skinnider LF
Cancer; 1994 Feb; 73(3):711-9. PubMed ID: 8299094
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of early stage primary tonsil non-Hodgkin's lymphoma].
Gao YH; Li YX; Zhao LJ; Yuan ZY; Liu XF; Yu ZH
Zhonghua Xue Ye Xue Za Zhi; 2003 Apr; 24(4):190-2. PubMed ID: 12864949
[TBL] [Abstract][Full Text] [Related]
17. Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma.
Kato I; Booza J; Quarshie WO; Schwartz K
J Registry Manag; 2012; 39(4):158-66. PubMed ID: 23493021
[TBL] [Abstract][Full Text] [Related]
18. Progressive disease following autologous transplantation in patients with chemosensitive relapsed or primary refractory Hodgkin's disease or aggressive non-Hodgkin's lymphoma.
Kewalramani T; Nimer SD; Zelenetz AD; Malhotra S; Qin J; Yahalom J; Moskowitz CH
Bone Marrow Transplant; 2003 Oct; 32(7):673-9. PubMed ID: 13130314
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic characteristics and therapeutic outcomes of primary gastrointestinal non-Hodgkin's lymphomas in central Anatolia, in Turkey.
Eser B; Kaplan B; Unal A; Canoz O; Altuntas F; Sari HI; Er O; Ozkan M; Kucuk C; Arar M; Gursoy S; Cetin M
Yonsei Med J; 2006 Feb; 47(1):22-33. PubMed ID: 16502482
[TBL] [Abstract][Full Text] [Related]
20. Risk factors predicting graft-versus-host disease and relapse-free survival after allogeneic hematopoietic stem cell transplantation in relapsed or refractory non-Hodgkin's lymphoma.
Jeon YW; Yoon S; Min GJ; Park SS; Park S; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Lee JW; Cho SG
Ann Hematol; 2019 Jul; 98(7):1743-1753. PubMed ID: 31089793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
